OFG
OmniStar Financial Group’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,778
| Closed | -$585K | – | 129 |
|
|
2023
Q4 | $585K | Buy |
15,778
+211
| +1% | +$7.82K | 0.73% | 52 |
|
|
2023
Q3 | $565K | Sell |
15,567
-4,361
| -22% | -$158K | 0.67% | 51 |
|
|
2023
Q2 | $710K | Sell |
19,928
-1,235
| -6% | -$44K | 0.83% | 43 |
|
|
2023
Q1 | $753K | Sell |
21,163
-502
| -2% | -$17.9K | 0.96% | 34 |
|
|
2022
Q4 | $761K | Buy |
+21,665
| New | +$761K | 0.87% | 43 |
|
|
2022
Q3 | – | Sell |
-11,014
| Closed | -$479K | – | 115 |
|
|
2022
Q2 | $479K | Sell |
11,014
-1,114
| -9% | -$48.4K | 0.53% | 69 |
|
|
2022
Q1 | $528K | Sell |
12,128
-89
| -0.7% | -$3.88K | 0.52% | 73 |
|
|
2021
Q4 | $538K | Buy |
+12,217
| New | +$538K | 0.55% | 69 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 114 |
|
|
2021
Q2 | – | Sell |
-12,032
| Closed | -$429K | – | 66 |
|
|
2021
Q1 | $429K | Sell |
12,032
-5,231
| -30% | -$187K | 0.55% | 66 |
|
|
2020
Q4 | $635K | Sell |
17,263
-3,323
| -16% | -$122K | 0.45% | 70 |
|
|
2020
Q3 | $775K | Buy |
20,586
+1,701
| +9% | +$64K | 0.58% | 56 |
|
|
2020
Q2 | $770K | Buy |
18,885
+2,371
| +14% | +$96.7K | 0.64% | 58 |
|
|
2020
Q1 | $626K | Sell |
16,514
-14,768
| -47% | -$560K | 0.62% | 53 |
|
|
2019
Q4 | $1.47M | Buy |
31,282
+713
| +2% | +$33.5K | 1.24% | 26 |
|
|
2019
Q3 | $1.31M | Buy |
30,569
+321
| +1% | +$13.7K | 1.14% | 35 |
|
|
2019
Q2 | $1.21M | Buy |
30,248
+590
| +2% | +$23.6K | 1.09% | 39 |
|
|
2019
Q1 | $1.24M | Buy |
29,658
+941
| +3% | +$39.3K | 1.09% | 40 |
|
|
2018
Q4 | $1.1M | Buy |
28,717
+20,020
| +230% | +$765K | 1.12% | 40 |
|
|
2018
Q3 | $349K | Buy |
8,697
+1,933
| +29% | +$77.6K | 0.27% | 87 |
|
|
2018
Q2 | $272K | Sell |
6,764
-1,814
| -21% | -$72.9K | 0.26% | 94 |
|
|
2018
Q1 | $335K | Buy |
8,578
+997
| +13% | +$38.9K | 0.32% | 80 |
|
|
2017
Q4 | $268K | Buy |
+7,581
| New | +$268K | 0.25% | 93 |
|